Company / Working Capital per Share
NRX Pharmaceuticals, Inc. Working Capital per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$1.35
FY2025
5-year range
-$2.21 / -$1.35
FY2024-FY2025
Trend
+39.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-1.35 in FY2025.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share increased 39.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -5.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.35 | +39.0% |
| FY2024 | -$2.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026